Coverage of the satellite symposium session "Emerging treatments for patients with cancer: practical guidelines and expert insights" presented at the European Society for Medical Oncology (ESMO) 2017 Congress on Monday 11 September 2017 in Madrid, Spain.
The symposium was supported by Tesaro,...
Iain McNeish discusses the role of PARP inhibitors, including rucaparib in the treatment of ovarian cancer.
Part 2 of 3 – Dr Domenica Lorusso discusses the ICON 6 trial and the difficulties in analyzing survival benefits in ovarian cancer patients. She also discusses the ANTHALYA study and toxicity of bevacizumab.
Speaker disclosures: Advisory Board for Clovis Oncology, Astra Zeneca, PharmaMar,...
Part 1 of 3 – Dr Domenica Lorusso discusses the results of the phase III LION study and the DESKTOP III trial in ovarian cancer.
Speaker disclosures: Advisory Board for Clovis Oncology, Astra Zeneca, PharmaMar, Roche.
Filmed at the American Society of Clinical Oncology (ASCO) Annual...
Coverage of the satellite symposium session "A New PARP Inhibitor to Clinical Practice" presented at ECCO 2017.
The symposium was supported by Tesaro, who provided this video coverage.
Dr Christian Marth discusses neoadjuvant chemotherapy and upfront surgery in ovarian cancer.
FILMED AT THE EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY (ESMO) ANNUAL MEETING, OCTOBER 2016.